AI Assistant
Blog
Pricing
Log In
Sign Up
128 In silico analysis of the immune checkpoint TIGIT as a novel immunotherapy target for high grade serous ovarian cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
